DSGN:NASDAQ, Design Therapeutics, Inc.

DSGN stock overview

Design Therapeutics, Inc. (DSGN:NASDAQ) closed at $9.32 on November 19, 2026, down 1.58% on the day. The stock trades 46.0% below its 52-week high of $17.25 and 19.3% above its 52-week low of $7.81. Over the past year, it gained 18.4%. Design Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$9.32
Day change
-1.58%
Volume
266,861
Average volume
562,721
Market cap
596M+
52-week range
$7.81 – $17.25
50-day average
$11.36
200-day average
$12.18

Price action over the past year

In 252 trading sessions since November 19, 2025, DSGN closed higher on 128 days (51%). Its best day was April 29, 2026 (+23.26%) and its worst was May 18, 2026 (-25.54%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

DSGN news

About Design Therapeutics, Inc.

Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

Similar stocks

Find more stocks like DSGN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.